Parameter
| Biomarker | anti-MCV | Full name | Antimutant carnosine waveform protein antibody | Molecular Type | protein (autoantibody ) |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Early diagnosis and disease monitoring | ||
| Disease | Rheumatoid Arthritis (RA) | Disease Subtypes | / | ||
| Organ | Joint (Synovium) | Test Sample / Technology Platform | Serum, synovial fluid (ELISA, electrochemical immunoassay platform) | ||
| Pathobiological Mechanisms | Regarding carboxylic acid modified proteoglycan, it is involved in synovial hyperplasia and pannus formation | ||||
| Clinical Availability Status | Clinical | ||||
| Notes and Dynamics | The level is positively correlated with disease activity, and predicts joint erosion better than anti-CCP. | ||||